Desipramine-induced lysosomal vacuolization is independent of autophagy

Cell Biol Int. 2018 Feb;42(2):248-253. doi: 10.1002/cbin.10901. Epub 2017 Dec 10.

Abstract

Desipramine, a commonly used antidepressant drug, induced cytosolic vacuolization in L929 cells. The level of LC3-II was elevated and that of p62 was reduced in desipramine-treated L929 cells, indicating the induction of autophagy by desipramine. Surprisingly, massive vacuolization was observed in desipramine-treated L929 cells in the presence of LY294002, an inhibitor of autophagy. On the other hand, bafilomycin A1, an inhibitor of vacuolar type H+ ATPase, almost completely inhibited vacuolization in desipramine- or desipramine/LY294002-treated L929 cells. Furthermore, desipramine-induced vacuolization was observed in autophagy-deficient Atg7-/- mouse embryonic fibroblasts (MEFs) as well as wild-type Atg7+/+ MEFs. These results demonstrate that desipramine-induced lysosomal vacuolization is independent of autophagy.

Keywords: autophagy; desipramine; lysosome; tricyclic antidepressants; vacuolization.

MeSH terms

  • Animals
  • Antidepressive Agents, Tricyclic / pharmacology*
  • Autophagy
  • Autophagy-Related Protein 7 / genetics
  • Cell Line, Tumor
  • Cells, Cultured
  • Desipramine / pharmacology*
  • Lysosomes / drug effects*
  • Macrolides / pharmacology
  • Mice
  • Vacuoles / drug effects*

Substances

  • Antidepressive Agents, Tricyclic
  • Atg7 protein, mouse
  • Macrolides
  • bafilomycin A1
  • Autophagy-Related Protein 7
  • Desipramine